A microscopic discovery in a California lake sparked buzz and controversy more than a decade ago when it was first revealed.

As the Trump administration reshapes biomedicine, it wants to change how scientists test drug safety: animal research.

Adhesives found in sports products contribute to ocean pollution. A Lafayette based company may have found a cleaner solution.

ASPIRE-BioNEST at UoH and Tulsi Therapeutics announce world’s first successful pre-clinical trial of Stem Cell–Exosome ...

Science, a top research journal, said there was no evidence of misconduct by researchers whose finding attracted heavy attention and scrutiny in social media’s early days.

In a landmark moment for India’s biotechnology sector, Hyderabad-based biotech startup Tulsi Therapeutics, which focused on regenerative medicine using stem cells and exosomes, and ASPIRE-BioNEST, ...

An international joint research effort has created a new standard framework that simplifies and enhances the accuracy and ...

New observations fail to confirm signs of life in the atmosphere of the distant planet K2-18b. They also raise questions ...

Tulsi Therapeutics achieves groundbreaking success with novel stem cell–exosome therapy for chronic liver failure at ...

Researchers used stable isotope and proteomic analyses on medieval European skeletons to uncover the details of ancient diets ...

Chronic hepatitis B treatment relies on nucleoside or nucleotide analogue drugs that suppress hepatitis B virus (HBV) ...

InGeneron, Inc., a biotechnology company pioneering autologous regenerative cell therapies, today announced the publication of a pivotal preclinical study in the International Journal of Molecular Sci ...